Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

New mechanism for cancer progression discovered by UNC and Harvard researchers

27.11.2012
The protein Ras plays an important role in cellular growth control. Researchers have focused on the protein because mutations in its gene are found in more than 30 percent of all cancers, making it the most prevalent human oncogene.
University of North Carolina Lineberger Comprehensive Cancer Center and Harvard researchers have discovered an alternative mechanism for activating Ras that does not require mutation or hormonal stimulus. In healthy cells, Ras transmits hormone signals into the cell that prompt responses such as cell growth and the development of organs and tissues. A mutation on the RAS gene can chronically activate those signals, leading to tumor initiation and progression.

In an article published on-line in a November issue of Nature Structural and Molecular Biology, the UNC and Harvard teams discovered that modification of Ras at a specific site with a small protein known as ubiquitin can also lock Ras into an active signaling state. Thus, modification of Ras with a single ubiquitin – a process known as monoubiquitination - switches Ras to an active signaling state by disrupting the action of another protein known as the GTPase activating protein, or GAP. Work by two of the papers co-authors, Atsuo Sasaki and Lewis Cantley of Harvard, had previously found evidence for Ras’s potential to become activated and promote Ras-mediated tumorigenesis by monoubiquitination.

Because of the strong link between Ras and cancer, Ras should be an attractive target for drug discovery efforts. Despite considerable efforts at developing treatments targeting the protein, Ras itself is now considered to be ‘undruggable’, leading researchers to try new approaches to developing drugs that target activated Ras. This could lead to benefits beyond cancer therapies, as the RAS gene has also been linked to developmental disorders such as Noonan syndrome, Costello syndrome and autoimmune lymphoproliferative syndrome.

Lead researcher Rachael Baker, a PhD candidate doing joint work in the labs of Henrik Dohlman, PhD, professor of pharmacology and vice chair of biochemistry and biophysics and Sharon Campbell, PhD, professor of biochemistry and biophysics at UNC, developed a novel method to modify Ras with ubiquitin and then subsequently characterized how ubiquitin modification can lead to Ras activation.

The attachment of ubiquitin to Ras at a specific site leads to Ras activation, much like with an oncogenic mutation, leading to an increased potential for cancer formation. Baker notes that the reaction can be reversed by enzymes in the cell that remove ubiquitin, making these enzymes possible targets for future pharmaceutical research.

“Establishing how Ras is activated by ubiquitin is just the first step in understanding this novel mechanism of cellular regulation.” said Campbell.

The researchers next step will be to obtain a more detailed understanding of its role in cancer progression, first in cells and in animals and eventually in cancer patients.

Research was done in conjunction with Brian Kuhlman and Steven Lewis in the UNC Department of Biochemistry and Biophysics. The work was supported by NIH grants R01CA089614 (S.L.C.), R01GM073180–06S1 (H.G.D.), R01GM073960 and R01GM073151, and R01GM41890 and P01CA117969 (L.C.C.), the Program in Molecular and Cellular Biophysics and NIH grant T32GM008570, the Japanese Society for the Promotion of Science Research Fellowship for Research Abroad, Kanae Foundation for Research Abroad and a Genentech Fellowship.

William Davis | EurekAlert!
Further information:
http://www.unc.edu

More articles from Life Sciences:

nachricht Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University

nachricht How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Lässt sich mit Boten-RNA das Immunsystem gegen Staphylococcus aureus scharf schalten?

Staphylococcus aureus ist aufgrund häufiger Resistenzen gegenüber vielen Antibiotika ein gefürchteter Erreger (MRSA) insbesondere bei Krankenhaus-Infektionen. Forscher des Paul-Ehrlich-Instituts haben immunologische Prozesse identifiziert, die eine erfolgreiche körpereigene, gegen den Erreger gerichtete Abwehr verhindern. Die Forscher konnten zeigen, dass sich durch Übertragung von Protein oder Boten-RNA (mRNA, messenger RNA) des Erregers auf Immunzellen die Immunantwort in Richtung einer aktiven Erregerabwehr verschieben lässt. Dies könnte für die Entwicklung eines wirksamen Impfstoffs bedeutsam sein. Darüber berichtet PLOS Pathogens in seiner Online-Ausgabe vom 25.05.2017.

Staphylococcus aureus (S. aureus) ist ein Bakterium, das bei weit über der Hälfte der Erwachsenen Haut und Schleimhäute besiedelt und dabei normalerweise keine...

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: Orientierungslauf im Mikrokosmos

Physiker der Universität Würzburg können auf Knopfdruck einzelne Lichtteilchen erzeugen, die einander ähneln wie ein Ei dem anderen. Zwei neue Studien zeigen nun, welches Potenzial diese Methode hat.

Der Quantencomputer beflügelt seit Jahrzehnten die Phantasie der Wissenschaftler: Er beruht auf grundlegend anderen Phänomenen als ein herkömmlicher Rechner....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Tumult im trägen Elektronen-Dasein

Ein internationales Team von Physikern hat erstmals das Streuverhalten von Elektronen in einem nichtleitenden Material direkt beobachtet. Ihre Erkenntnisse könnten der Strahlungsmedizin zu Gute kommen.

Elektronen in nichtleitenden Materialien könnte man Trägheit nachsagen. In der Regel bleiben sie an ihren Plätzen, tief im Inneren eines solchen Atomverbunds....

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Meeresschutz im Fokus: Das IASS auf der UN-Ozean-Konferenz in New York vom 5.-9. Juni

24.05.2017 | Veranstaltungen

Diabetes Kongress in Hamburg beginnt heute: Rund 6000 Teilnehmer werden erwartet

24.05.2017 | Veranstaltungen

Wissensbuffet: „All you can eat – and learn”

24.05.2017 | Veranstaltungen

 
VideoLinks
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

DFG fördert 15 neue Sonderforschungsbereiche (SFB)

26.05.2017 | Förderungen Preise

Lässt sich mit Boten-RNA das Immunsystem gegen Staphylococcus aureus scharf schalten?

26.05.2017 | Biowissenschaften Chemie

Unglaublich formbar: Lesen lernen krempelt Gehirn selbst bei Erwachsenen tiefgreifend um

26.05.2017 | Gesellschaftswissenschaften